News|Articles|February 10, 2023
SCOPE 2023: Challenging Operational Aspects of Clinical Trials
Author(s)Lisa Henderson
Len Rosenberg, head of clinical operations at Beat AML, reveals how changing the backbone treatment to a different regimen is beneficial to the patient, in terms of the safety with the same efficacy.
Advertisement
In an interview at the 2023 SCOPE conference with ACT Editor-in-Chief, Lisa Henderson, Len Rosenberg, head of clinical operations at Beat AML, explains the operational obstacles that come with clinical trials, including background treatment dosages.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
SCOPE X: The COPD Case Study That Shows What AI Can Do for Enrollment
3
SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years
4
A Shot in the Arm to Traditional Vaccine Trial Strategy
5